Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Parkinson's disease

Journal of Neural Transmission

Volumn 104, Issue 11-12, 1997, Pages 1287-1293

  Molina, J A ^a   De Bustos, F ^a   Jimenez Jinienez F J ^b,d   Benito Leon J ^a   Orti Pareja M ^b   Gasalla, T ^b   Tallon Barranco A ^b   Navarro, J A ^a   Arenas, J ^a   Enriquez De Salamanca R ^c  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d NONE   (Spain)

Author keywords

Alpha tocopherol; Cerebrospinal fluid levels; Parkinson's disease; Serum levels; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; RATING SCALE; RISK; STAGING; VITAMIN BLOOD LEVEL;

AGED; ANTIPARKINSON AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; REFERENCE VALUES; VITAMIN E;

EID: 6844266281     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01294729     Document Type: Article

References (34)

1. Abbott RA, Cox M, Markus H, Tomkins A (1992) Diet, body size and micronutrient status in Parkinson's disease. Eur J Clin Nutr 46: 879-884
2. Adams JD Jr, Odunze IN, Sevanian A (1990) Induction by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of lipid peroxidation in vivo in vitamin E deficient mice. Biochem Pharmacol 39: R5-R8
3. Ahlskog JE, Uitti RJ, Low PA, Tyce GM, Nickander KK, Petersen RC, Kokmen E (1995) No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease. Mov Disord 10: 566-573
4. Ayuso-Peralta L, Jiménez-Jiménez FJ, Cabrera-Valdivia F, Molina JA, Rabasa M, Almazán J, Tabernero C, de Pedro-Cuesta J, Giménez-Roldán S (1997) Premorbid dietetic habits and risk for Parkinson's disease. Parkinsonism Rel Disord 3: 55-61
5. Baldessarini RJ, Kula NS, Francouer D, Finklestein SP (1986) Antioxidants fail to inhibit depletion of striatal dopamine by MPTP. Neurology 36: 735
6. Cadet JL, Katz M, Jackson-Lewis V, Fahn S (1989) Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: behavioral and biochemical evidence. Brain Res 476: 10-15
7. Dexter DT, Ward RH, Wells FR, Daniel SE, Lees AJ, Peters TJ, Jenner P, Marsden CD (1992) Alpha-tocopherol levels in brain are not altered in Parkinson's disease. Ann Neurol 32: 591-593
8. Dexter DT, Brooks DJ, Harding AE, Burn DJ, Muller DP, Goss-Sampson MA, Jenner PG, Marsden CD (1994) Nigrostriatal function in vitamin E deficiency: clinical, experimental and positron emission tomographic studies. Ann Neurol 35: 298-303
9. Fahn S (1991) An open trial of high-dosage antioxidants in early Parkinson's disease. Am J Clin Nutr 53 [Suppl 1]: 380-382
10. Fahn S, Cohen G (1992) The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann Neurol 32: 804-812
11. Fahn S, Elton RL, and members of the UPDRS Development Committee (1987) Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden SD, Goldstein M, Calne DB (eds) Recent developments in Parkinson's disease, vol II. Florham Park, New Jersey, pp 153-163
12. Fernández-Calle P, Molina JA, Jiménez-Jiménez FJ, Vázquez A, Pondal M, García-Ruiz PJ, Urra DG, Domingo J, Codoceo R (1992) Serum levels of alpha-tocopherol (vitamin E) in Parkinson's disease. Neurology 42: 1064-1066
13. Golbe LI, Farrell TM, Davis PH (1988) Case-control study of early life dietary factors in Parkinson's disease. Arch Neurol 45: 1350-1353
14. Golbe LI, Farrell TM, Davis PH (1990) Follow-up study on early-life protective and risk factors in Parkinson's disease. Mov Disord 5: 66-70
15. Golbe LI, Liu JC, Stern MB, Dranoff J (1992) Premorbid dietary factors in young-onset Parkinson's disease (YOPD). Mov Disord 7 [Suppl 1]: 76
16. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17: 427-442
17. Hughes AJ, Ben-Shlomo SE, Daniel SE, Lees AJ (1992) What features improve the accuracy of clinical diagnosis in Parkinson's disease? A clinicopathological study. Neurology 42: 1142-1146
18. Jiménez-Escrig A, Martínez-Castrillo JC, García-Segovia J, Orensanz L, Sanz-Anquela JM, Ribera-Casado JM (1993) Dietetic habits in Parkinson's disease. XVth World Congress of Neurology, Vancouver, Canada, September 1993. Can J Neurol Sci [Suppl 4]: S212
19. King D, Playfer JR, Roberts NB (1992) Concentrations of vitamins A, C, and E in elderly patients with Parkinson's disease. Postgrad Med J 68: 634-637
20. Martinovits G, Melamed E, Cohen O, Rosenthal J, Uzzan A (1986) Systemic administration of antioxidants does not protect mice against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3.6-tetrahydropyridine (MPTP). Neurosci Lett 69: 192-197
21. Morens DM, Grandinetti A, Waslien CI, Park CB, Ross GW, White LR (1996) Case-control study of idiopathic Parkinson's disease and dietary vitamin E intake. Neurology 46: 1270-1274
22. Moreu E, Molinero LM, Fernández E (1990) R-Sigma: Base de datos bioestadística para un ordenador personal. Horus Hardware, Madrid
23. Odunze IN, Klaidman LK, Adams JD Jr (1990) MPTP toxicity in the mouse brain and vitamin E. Neurosci Lett 108: 346-349
24. Orensanz L, Jiménez-Escrig A, Martínez-Castrillo JC, García-Segovia J, Sanz-Anquela JM, Ribera-Casado JM (1993) Diet vitamins in Parkinson's disease. XVth World Congress of Neurology, Vancouver, Canada, September 1993. Can J Neurol Sci [Suppl 4]: S212
25. Pappert EJ, Tangney CC, Goetz CG, Ling ZD, Lipton JW, Stebbins GT, Carvey PM (1996) Alpha-tocopherol in the ventricular cerebropinal fluid of Parkinson's disease patients: dose-response study and correlations with plasma levies. Neurology 47: 1037-1042
26. Perry TL, Yong RM, Clavier K, Jones K, Wright JM, Foulks JG, Wall RA (1985) Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouse. Neurosci Lett 60: 109-114
27. Perry TL, Yong VW, Hansen S, Jones K, Bergeron C, Foulks JG, Wright JM (1987) α-tocopherol and β-carotene do not protect marmosets against the dopaminergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J Neurol Sci 81: 321-331
28. Tanner CM, Cohen JA, Summerville BC, Goetz CG (1988) Vitamin use and Parkinson's disease. Ann Neurol 24: 182
29. Tanner CM, Chem B, Cohen JA, Wang W, Peng M, Summerville BC, Liu Z, Liang X, Kao LC, Goetz CG (1989) Dietary antioxidant vitamins and the risk of developing Parkinson's disease. Neurology 39 [Suppl]: 181
30. The Parkinson Study Group (1993) Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 328: 176-183
31. Tohgi H, Abe T, Saheki M, Hamato F, Sasaki K, Takahashi S (1995) Reduced and oxidized forms of glutathione and α-tocopherol in the cerebrospinal fluid of parkinsonian patients: comparison between before and after L-dopa treatment. Neurosci Lett 184: 21-24
32. Vatassery GT, Nelson MJ, Maletta GJ, Kuskowski MA (1991) Vitamin E (tocopherols) in human cerebrospinal fluid. Am J Clin Nutr 53: 95-99
33. Vieregge P, Maravic CV, Friedrich HJ (1992) Life-style and dietary factors early and late in Parkinson's disease. Can J Neurol Sci 19: 170-173
34. Yong WW, Perry TL, Krisman AA (1986) Depletion of glutathione in brainstem of mice caused by N-methyl-4-phenyl-1,2.3,6-tetrahydropyridine is prevented by antioxidant pretreatment. Neurosci Lett 63: 56-60